No.6 Eptinezumab-jjmr- (VYEPTI) - (Feb 2020) 

PATIENT COUNSELING INFORMATION

Advise the patient to read the FDA-approved patient labeling (Patient Information).

Hypersensitivity Reactions-                                                                                       Inform patients that hypersensitivity reactions, including angioedema, urticaria, facial flushing, and rash, can occur. 

Advise patients to contact their healthcare provider immediately if signs or symptoms of hypersensitivity reactions occur.

Pregnancy-                                                                                                              Advise patients to notify their healthcare provider if they become pregnant during treatment or plan to become pregnant 

Lactation-                                                                                                               Inform patients to notify their healthcare provider if they are breastfeeding or plan to breastfeed 

Manufactured by: Lundbeck Seattle BioPharmaceuticals, Inc. 11804 North Creek Parkway South Bothell, WA 98011 USA U.S. License No.

XXXX Vyepti is a trademark of Lundbeck Seattle BioPharmaceuticals, Inc.